Here are five articles published by Becker's Hospital Review this week, highlighting a COO's thoughts on performance dashboards, a nationwide recall of Lupin's antidepressant drug Paroxetine and Cardinal Health's potential divestiture of its China unit, among other topics.
1. A supply chain expert on what your performance dashboard is missing
Supply chain key performance indicator dashboards must provide more information than just current business metrics, according to Sujit Singh, COO of the supply chain software solutions provider Arkieva.
2. Lupin recalls 12k bottles of antidepressant
Lupin Pharmaceuticals voluntarily recalled 12,480 bottles of its Paroxetine extended-release antidepressant tablets.
3. House approves bill extending time for devicemakers to report defects: 3 takeaways
The Food and Drug Administration user fee reauthorization bill, which House representatives passed Wednesday, contains a measure to triple the amount of time device companies have to report product issues.
4. Herbal coffee recalled for containing erectile dysfunction drug ingredient
Grand Prairie, Texas-based Bestherbs Coffee voluntarily recalled its New of Kopi Jantan Tradisional Natural Herbs Coffee July 13 after a Food and Drug Administration laboratory analysis detected an undeclared active drug ingredient.
5. Supply chain manager ranked No. 4 most competitive high-paying job by Glassdoor
Supply chain manager earned the No. 4 spot on Glassdoor's list of the 20 most in-demand jobs with salaries over $100,000.
6. Cardinal Health puts $1.5B China business up for sale, sources say
Dublin, Ohio-based Cardinal Health is looking to sell its China business in a deal that could be worth up to $1.5 billion.
More articles on supply chain:
Puma Biotech earns FDA approval for breast cancer drug
More than 30 new Alzheimer's drugs poised for release in next 5 years
Merck to build tech hub in Texas